The present study aimed to analyze the PD-L1+ CSCs in the context of T-cell subtypes frequencies and expression of immunomodulatory molecules in metastatic and non-metastatic LNs of non-small cell lung cancer (NSCLC) patients. This evidence concerns the gene CD274 and non-small cell lung carcinoma.